AeroVironment: $465M Contract, -44% YTD, Earnings Tomorrow
AeroVironment reports Q1 FY2027 after the close September 9. Options price a 13% move. Here's what the $464.8M Army contract and litigation mean for traders.
Key Points
- AeroVironment secured a $464.8 million U.S. Army laser weapon systems contract, but AVAV shares are still down 44.5% year to date near $142, reflecting contract termination fallout, accounting issues, and active class-action litigation.
- Options are pricing a ±13% move on tomorrow's Q1 FY2027 report, against Wall Street consensus of $459.9 million in revenue (+1.2% YoY) and $0.30 EPS — a sharp deceleration from the 133% revenue growth posted last quarter.
- The $142 share price level and the $459.9 million revenue hurdle are the two concrete markers traders must watch when results hit after tomorrow's close.
AeroVironment just won a $464.8 million U.S. Army contract for laser weapon systems, and the stock is still down 44.5% for the year. That gap between contract wins and share price performance is the entire story of what has happened to AVAV in 2026 — and it makes tomorrow's Q1 FY2027 earnings report after the close one of the most asymmetrically positioned defense stock events of the quarter. The options market agrees: traders are pricing a ±13% move, a figure that has been consistently understated in AVAV's recent earnings history.
A Damaged Stock With a Real Business Underneath
To understand why AVAV is trading near $142 with a $464.8 million contract in hand, you need to reconstruct the sequence of damage that has occurred since late 2025. The stock peaked on extraordinary momentum: last quarter, AeroVironment reported revenues of $641.6 million, up 133% year over year, with beats on EPS, revenue, and EBITDA. That was a quarter that looked like the beginning of a sustained defense-tech supercycle. Then the wheels came off. A contract termination — tied to a multi-vendor SCAR procurement competition — hit simultaneously with the disclosure of accounting issues, creating the worst possible combination for institutional holders who had built large positions on the growth narrative.
The class-action litigation that followed compounded the damage. Lawsuits filed on behalf of investors who purchased AVAV shares between June 25, 2025 and March 10, 2026 allege that the company understated competitive risks in the SCAR procurement and overstated its business and financial prospects during that window. Lead plaintiff status is still being sought, meaning the litigation timeline extends well into 2027 and beyond. For any institutional investor with compliance constraints around litigation exposure, AVAV is effectively untouchable until the legal picture clarifies — and that dynamic alone explains a significant portion of the 44.5% YTD drawdown that has not been recovered despite the Army laser contract win.
The new $464.8 million Army contract is genuinely significant. It positions AeroVironment in the counter-drone and directed energy market at a moment when demand from the U.S. military is accelerating under the geopolitical pressures visible in today's market backdrop — Iran's escalating threats have oil surging and defense stocks broadly in focus. But a contract win does not immediately translate into reported revenue, and tomorrow's Q1 FY2027 results will reflect a period before that contract award flows meaningfully into the income statement.
The Numbers That Define Tomorrow's Report
Wall Street's consensus for Q1 FY2027 is revenue of $459.9 million, representing growth of just 1.2% year over year. That is a dramatic deceleration from the 133% growth posted last quarter and the 140% increase recorded in Q1 FY2026. The EPS consensus sits at $0.30, which would be down 6.3% from the same quarter a year ago. These are not numbers that inspire confidence on their face — but they need to be read in context of what the Street has already reset expectations to after months of downward revisions driven by the contract termination and accounting review.
The critical question for tomorrow is not whether AeroVironment hits $459.9 million. It is whether the company can demonstrate that the accounting issues are fully resolved, that the SCAR contract loss is a contained setback rather than a symptom of broader competitive deterioration, and that the backlog and pipeline — now bolstered by the $464.8 million laser weapon contract — support a credible return to growth in the back half of FY2027. If management can thread that needle, the stock has enormous room to recover from $142. If the call reveals any incremental negative on litigation exposure or additional contract disputes, the -44.5% YTD becomes -55% before the week is out.
The options history here is instructive and should not be dismissed as noise. On June 24, 2025, AVAV moved 25.9% against an implied move of just 9.8%. On December 4, 2024, it moved 15.7% against an implied of 10.7%. In both cases, the realized move substantially exceeded what the options market priced. Tomorrow's ±13% implied is already elevated relative to most defense names, and AVAV's history suggests the actual move could be materially larger in either direction. Traders using options to express a directional view tonight should size around the possibility of a 20%+ move — not 13%.
What Traders Watch From Here
The specific setup into tomorrow's close is this: AVAV at roughly $142, with $459.9 million in revenue and $0.30 EPS as the consensus bar, and a ±13% options-implied move that has historically been a floor rather than a ceiling. The geopolitical backdrop — Iran escalating, oil surging, defense spending expectations rising — is a macro tailwind that should in theory benefit AeroVironment's narrative. But macro tailwinds do not resolve class-action litigation, and they do not tell you whether the Army's $464.8 million laser contract will appear in the formal backlog disclosure tomorrow night.
The backlog number is the sleeper metric in this report. AeroVironment's contracted backlog is the clearest leading indicator of where revenue goes over the next four quarters, and a backlog that has grown materially — incorporating the new Army contract and any other awards not yet publicly disclosed — would be the single most bullish data point management could deliver. Conversely, if backlog has shrunk relative to the prior quarter despite the new contract, it signals that the SCAR termination damage runs deeper than the market has priced.
Position sizing discipline is essential given the litigation overhang. Traders with a bullish thesis on AVAV's fundamental recovery should be aware that any settlement announcement or adverse legal ruling — on a timeline entirely outside the company's control — can move the stock 10% in a single session independent of operating performance. The broader market context today — Dow futures negative, geopolitical risk elevated, rate-hike expectations fresh off Friday's jobs print — argues for smaller position sizes and defined-risk structures going into binary events. The specific level to watch on a bullish resolution is $165, which represents approximately the 16% recovery that would begin to fill the gap created by the March 2026 selloff. On a miss, $125 is the next identifiable support zone, representing a further 12% decline from current levels and a test of lows not visited since early 2024.
The Weekly Investor
Daily market analysis for active traders. Free.
